Data protection Impressum

Investment

The latest edition of the Swiss Biotech Report underscores the continued growth and resilience of Switzerland’s biotech sector, attributing success to strong international collaborations and innovative advancements that promise to reshape healthcare worldwide.

The Swiss biotech industry: building resilience through global alliances

6 May 2025

Burgdorf-based medtech Ypsomed has announced the sale of its diabetes care business to TecMed AG for up to CHF 420 million. The move marks a significant strategic shift, positioning Ypsomed as a pure-play provider of self-injection systems for pharmaceutical and biotech partners worldwide.

Bern-based Ypsomed pivots with CHF 420 million diabetes unit sale to TecMed

23 April 2025

Top Stories Western Switzerland

Top Stories from Western Switzerland (April 2025)

23 April 2025

From clinical research to international leadership, Incyte’s steady growth in Western Switzerland showcases the region’s strength in biopharmaceutical innovation.

Incyte, a key player in Western Switzerland’s biopharmaceutical innovation landscape

Toblerone strengthens its Swiss roots with CHF 65 million investment in Bern

14 April 2025

The CHUV has officially inaugurated its new Children’s Hospital in Lausanne, consolidating pediatric care and setting a new standard for child-centered healthcare infrastructure in Western Switzerland.

CHUV’s new Children’s Hospital enhances pediatric care in Western Switzerland

8 April 2025

A new privately funded health innovation campus will take shape in Meyrin, combining clinical care, research, and industry in one integrated ecosystem.

Campus Santé, a landmark investment in Geneva’s future of healthcare and research

7 April 2025

Albert School, the business and data school, is setting up in Geneva, marking a new stage in its international expansion. The private higher education institution, founded in Paris in 2022, will open the doors of its first Swiss campus in the Étang district of Vernier in September 2025.

Albert School opens its first Swiss campus in Geneva

3 April 2025

With over 30 years of presence in Le Locle, Jabil has established itself as a key player in Neuchâtel’s advanced manufacturing landscape.

Jabil, driving medical innovation from the heart of Neuchâtel’s industrial ecosystem

2 April 2025

French investment firm Matis has set up operations in Geneva with the launch of Matis Art Club Deals Suisse SA, marking a significant step in its mission to make 20th-century masterpieces accessible to investors through an innovative co-investment model.

Matis establishes first Swiss office in Geneva to democratize art investment

12 March 2025

1 2 3 4 5 … 18